We examined the levels of thrombopoietin (TPO) in the plasma of 42 patients to determine the probability of identifying patients positive for platelet antibodies as ITP patients, in which TPO levels are normal/non-elevated [18,19]. This evidence concerns the gene TPO and autoimmune thrombocytopenic purpura.